{
  "timestamp": "2026-02-24T12:10:01.145253+00:00",
  "total_entries": 206,
  "avg_quality": 2.65,
  "recent_30_avg": 2.41,
  "high_quality_count": 0,
  "low_quality_count": 0,
  "topic_averages": {
    "NAD+ therapy": 3.5,
    "rapamycin clinical trials": 3.4,
    "senolytics": 3.3,
    "longevity research": 3.0,
    "Federal Reserve interest rates": 2.9,
    "treasury bonds and interest rates": 2.8,
    "self-improvement and learning": 2.8,
    "AI agents and tool calling": 2.5,
    "compound-synthesis": 2.5,
    "bond market outlook": 2.4,
    "treasury-bonds": 2.3,
    "longevity": 2.3,
    "self-improvement": 2.0,
    "ai-agents": 2.0,
    "tool-calling": 2.0,
    "cross-domain-synthesis": 2.0
  },
  "score_distribution": {
    "1-2": 0,
    "2-3": 147,
    "3-4": 59,
    "4-5": 0
  }
}